ALNY vs CIMO
Alnylam Pharmaceuticals Inc (ALNY) versus Chimera Investment Corporation (CIMO) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Chimera Investment Corporation (CIMO) common stock listed on US.
Latest reported ALNY revenue for 2024-12-31 was $2.25B. Net income was -$278.2M. Revenue was up 23.0% from 2023-12-31 to 2024-12-31. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
CIMO does not have a complete income-statement cache yet.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. CIMO currently screens at market cap $0.
Not investment advice. Open the ALNY and CIMO stock pages for the full models.
Not investment advice.